psychiatry, which has thus far struggled to identify mechanistic pathways that may be leveraged for treatment outside of happenstance [e.g., the observed mood benefits of an agent developed to treat tuberculosis that inhibited monoamine oxidase and led to the development of modern antidepressant medications (Ramachandraih et al., 2011)].
